Telix Pharmaceuticals Limited (NASDAQ:TLX) Receives Average Rating of “Moderate Buy” from Analysts

Telix Pharmaceuticals Limited (NASDAQ: TLX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine research firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, six have assigned a buy rating and